The effect of sevoflurane and isoflurane on the neuromuscular block produced by vecuronium continuous infusion

Anesthesia and Analgesia

Volumn 82, Issue 5, 1996, Pages 942-947

  Kurahashi, Kiyoyasu ^a,b   Maruta, Hideo ^a  

^a Odawara Municipal Hospital   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEACETYLVECURONIUM; ATROPINE; DRUG METABOLITE; ISOFLURANE; NITROUS OXIDE; PETHIDINE; SEVOFLURANE; THIOPENTAL; UNCLASSIFIED DRUG; VECURONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; EAR NOSE THROAT SURGERY; FEMALE; HUMAN; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; PLASMA CLEARANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029880792     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199605000-00009     Document Type: Article

References (20)

1. Karis JH, Gissen AJ, Nastuk WL. The effect of volatile anesthetic agents on neuromuscular transmission. Anesthesiology 1967;28: 128-34.
2. Cannon JE, Fahey MR, Castagnoli KP, et al. Continuous infusion of vecuronium: the effect of anesthetic agents. Anesthesiology 1987;67:503-6.
3. Miller RD, Way WL, Dolan WM, et al. Comparative neuromuscular effects of pancuronium, gallamine, and succinylcholine during Forane and halothane anesthesia in man. Anesthesiology 1971;35:509-14.
4. Swen J, Gencarelli PJ, Koot HWJ. Vecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans. Anesth Analg 1985;64:411-4.
5. Fogdall RP, Miller RD. Neuromuscular effects of enflurane, alone and combined with d-tubocurarine, pancuronium, and succinylcholine, in man. Anesthesiology 1975;42:173-8.
6. Gissen AJ, Karis JH, Nastuk WL. Effect of halothane on neuromuscular transmission. JAMA 1966;197:770-4.
7. Rupp SM, Miller RD, Gencarelli PJ. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans. Anesthesiology 1984;60:102-5.
8. Miller RD, Way WL, Dolan WM, et al. The dependence of pancuronium- and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and Forane. Anesthesiology 1972;37:573-81.
9. Wright PMC, Hart P, Lau M, et al. The magnitude and time course of vecuronium potentiation by desflurane versus isoflurane. Anesthesiology 1995;82:404-11.
10. Itagaki T, Tai K, Katsumata N, Suzuki H. A clinical and experimental study on potentiation with sevoflurane of neuromuscular blocking effects of vecuronium and pancuronium. Masui [in Japanese; abstract in English]. 1988;37:943-54.
11. Shin Y-S, Miller RD, Caldwell JE, Eger El II, The neuromuscular effects of sevoflurane and isoflurane alone and in combination with vecuronium or atracurium in the rat. J Anesth 1992;6:1-8.
12. Tai K, Suzuki H, Itagaki T, et al. Influence of sevoflurane on neuromuscular blocking effects of vecuronium and pancuronium. Masui [in Japanese; abstract in English]. 1987;6:227-31.
13. Awata M. Clinical electromechanographic studies on potentiation of the pancuronium-induced neuromuscular blockade by new halogenated inhalation anesthetics. Masui [in Japanese; abstract in English]. 1987;36:1930-8.
14. Kato T, Ikeda K. The minimum alveolar concentration (MAC) of sevoflurane in humans. Anesthesiology 1987;66:301-3.
15. Stevens WC, Dolan WM, Gibbons RT, et al. Minimum alveolar concentrations (MAC) of isoflurane with and without nitrous oxide in patients of various ages. Anesthesiology 1975;42: 197-200.
16. Furuta T, Canfell PC, Castagnoli KP, et al. Quantitation of pancuronium, 3-desacetylpancuronium, vecuronium, 3-desacetylvecuronium, pipecuronium and 3-desacetylpipecuronium in biological fluids by capillary gas chromatography using nitrogen-sensitive detection. J Chromatogr 1988;427:41-53.
17. Marshall IG, Gibb AJ, Durant NN. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (ORG NC45) and its potential metabolites in the anaesthetized cat. Br J Anaesth 1983;55:703-14.
18. Caldwell JE, Szenohradszky J, Segredo V, et al. The pharmaco-dynamics and pharmacokinetics of the metabolite 3-desacetyl-vecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers. J Pharmacol Exp Ther 1994;270:1216-22.
19. Rowland M, Tozer TN. Constant rate intravenous infusion. In: Clinical pharmacokinetics: concepts and applications. Philadelphia: Lea & Febiger, 1980:97-106.
20. Waud BE, Waud DR. Effects of volatile anesthetics on directly and indirectly stimulated skeletal muscle. Anesthesiology 1979; 50:103-10.